▲ Peaking
Business
AbbVie inks $10.9B Apogee buyout to bag eczema prospect
1sources
1articles
0velocity
+0%since first seen
2h agofirst detected
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Coverage (1)
- AbbVie said to be reeling in Apogee and its Dupixent rival for almost $11B: report FirstWord Pharma · 21h ago
Related trends
▲ Peaking
Business
BTC analysis: SpaceX’s $600 billion plunge erased nearly half of bitcoin’s market cap in three days
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
What Trump’s Quantum Executive Orders Mean for IonQ and Infleqtion
▲ Peaking
Business
Updated live: Not all Prime Day deals are good
Consumer guides and live updates are emerging as Amazon Prime Day 2026 begins, highlighting a divide between top-rated deals and poor value offers.
▲ Peaking
Business
Stock Market Today: Tech Selloff Deepens, Oil Slips
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
▲ Peaking
Business
Oversized Trucks, SUVs Taking a Toll in America
▲ Peaking
Business
Prime Day deals are live: Shop the best sales from Apple, Adidas, Hanes, Shark and more up to 60% off
Amazon Prime Day has launched, featuring widespread discounts across various brands, though consumer guidance on deal quality is currently divided.